Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Leht 1 alates 17 tulemused
Use of fructose-based compounds for the diagnosis of cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF INVENTION
This invention relates to compositions, methods utilizing fructose and other monosaccharides for the diagnosis of cancer.
BACKGROUND
All publications herein are incorporated by reference to the same extent as if each individual publication or patent application was specifically
Fructose 1, 6-biphosphatases as new targets for diagnosing and treating breast cancer brain metastasis
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
GOVERNMENTAL SPONSORSHIP
Not Applicable.
FIELD OF THE INVENTION
The present invention is directed to compositions and methods for diagnosing and treating cancer cells by targeting fructose-1,6-biphosphatase(EC:3.1.311) enzymes (FBPs, type 1 and type 2) and/or their respective pathways. More
Fructose analogs and their combinations as anti-cancer agents
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The present invention relates to the field of biomedicine, and relates specifically to the use of fructose analogs and the combination of fructose analogs and glucose analogs in the treatment of cancer and organ fibrosis.
BACKGROUND
It is well known that the occurrence and
Fluorinated fructose derivatives for PET imaging
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention relates to fructose-based radiopharmaceuticals, pharmaceutical compositions comprising same, precursors and methods for preparing same, and methods of using same for diagnostic imaging of cancer cells and non-imaging tracer studies.
BACKGROUND OF THE
PFKB3 inhibitor for the treatment of a proliferative cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The presently disclosed subject matter relates to methods and compounds for reducing glycolytic flux. More particularly, the presently disclosed subject matter relates to aza chalcones and analogs thereof that inhibit 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3),
Inhibitors of PFKFB3 for cancer therapy
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention relates to inhibitors of mammalian energy metabolism, more particularly it relates to compounds used to inhibit one of the isozymes of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases (PFKFBs) involved in glycolysis, and more particularly it relates to
Methods and compositions for diagnosing and treating gastric cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates to the field of gastric cancer. More specifically, the present invention provides methods and compositions for diagnosing and treating gastric cancer.
BACKGROUND OF THE INVENTION
Gastric cancer (GC), a disease with a very poor prognosis, is the
Synthetic glycoamines and methods for their use that affect cell adhesion, inhibit cancer cell metastasis, and induce apoptosis
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates to pharmaceuticals that affect cell adhesion, inhibit cancer cell metastasis, and induce apoptosis both in vitro and in vivo.
Background of the Invention
Cell adhesion is one important property that differentiates multi-cellular organisms from
Family of PFKFB3 inhibitors with anti-neoplastic activities
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The presently disclosed subject matter relates to methods and compounds for reducing glycolytic flux. More particularly, the presently disclosed subject matter relates to aza chalcones and analogs thereof that inhibit 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3),
Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeutics
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The presently-disclosed subject matter relates to small-molecule inhibitors of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) and methods of using the same. In particular, the presently-disclosed subject matter relates to substituted benzindoles as PFKFB3 inhibitors and methods of
PFKFB3 inhibit and methods of use as an anti-cancer therapeutic
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The presently disclosed subject matter relates to a novel anti-cancer agent, (E)-1-(pyridyn-4-yl)-3-(7-(trifluoromethyl)quinolin-2-yl)-prop-2-e- n-1-one, as an inhibitor of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) and methods of using the same to treat cancer
PFKFB3 inhibitor and methods of use as an anti-cancer therapeutic
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The presently disclosed subject matter relates to a novel anti-cancer agent, (E)-1-(pyridyn-4-yl)-3-(7-(trifluoromethyl)quinolin-2-yl)-prop-2-e- n-1-one, as an inhibitor of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) and methods of using the same to treat cancer
PFKFB4 inhibitors and methods of using the same
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The presently-disclosed subject matter relates to 6-phosphofructo-2-kinase/fructose-2,6-bisphophatase 4 (PFKFB4) inhibitors and methods of using the same. In particular, the presently-disclosed subject matter relates to PFKFB4 inhibitors, including small interfering RNA
Physiologically active peptides and a process for preparation thereof
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The following examples illustrate the present invention, but it is to be understood that they are given for the purpose of illustration and not limitation.
EXAMPLE 1
A medium (100 l) containing 6.0% soluble starch, 4.0% cotton seed meal, 0.2% (NH.sub.4).sub.2 SO.sub.4, 0.1% yeast extract, 0.2%
Isolate of Antrodia camphorata process for producing a culture of the same and product obtained thereby
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates a process for culturing isolates of Antrodia camphorata to provide a product useful in medical and nourishment fields. The present invention also relates to a novel isolate of Antrodia camphorata, the culture of which exhibits pharmacological
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
